Delineation of the frequency and boundary of chromosomal copy number variations in paediatric neuroblastoma

References

• Maris JM. Matthay KK. Molecular biology of neuroblastoma. J Clin Oncol. 1999;17:2264–2279. doi:10.1200/JCO.1999.17.7.2264. PMID:10561284
   PubMed Web of Science ®Google Scholar
• Matthay KK, Maris JM, Schleiermacher G, et al. Neuroblastoma. Nature reviews Disease Primers. 2016;2:16078. doi:10.1038/nrdp.2016.78. PMID:27830764
   PubMed Web of Science ®Google Scholar
• Colon NC, Chung DH. Neuroblastoma. Advances in Pediatrics. .2011;58:297–311. doi:10.1016/j.yapd.2011.03.011. PMID:21736987
   PubMedGoogle Scholar
• Matthay KK, George RE, Yu AL. Promising therapeutic targets in neuroblastoma. Clin Cancer Res. 2012;18:2740–2753. doi:10.1158/1078-0432.ccr-11-1939. PMID:22589483
   PubMed Web of Science ®Google Scholar
• Janoueix-Lerosey I, Lequin D, Brugieres L, et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature. 2008;455:967–970. doi:10.1038/nature07398. PMID:18923523
   PubMed Web of Science ®Google Scholar
• Mosse YP, Laudenslager M, Longo L, et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature. 2008;455:930–935. doi:10.1038/nature07261. PMID:18724359
   PubMed Web of Science ®Google Scholar
• Chen Y, Takita J, Choi YL, et al. Oncogenic mutations of ALK kinase in neuroblastoma. Nature. 2008;455:971–974. doi:10.1038/nature07399. PMID:18923524
   PubMed Web of Science ®Google Scholar
• George RE, Sanda T, Hanna M, et al. Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature. 2008;455:975–978. doi:10.1038/nature07397. PMID:18923525
   PubMed Web of Science ®Google Scholar
• Mosse YP, Laudenslager M, Khazi D, et al. Germline PHOX2B mutation in hereditary neuroblastoma. Am J Hum Genet. 2004;75:727–730. doi:10.1086/424530. PMID:1182065
   PubMed Web of Science ®Google Scholar
• Cheung NK, Zhang J, Lu C, et al. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. Jama. 2012;307:1062–1071. doi:10.1001/jama.2012.228. PMID:3527076
   PubMed Web of Science ®Google Scholar
• Molenaar JJ, Koster J, Zwijnenburg DA, et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature. 2012;483:589–593. doi:10.1038/nature10910. PMID:22367537
   PubMed Web of Science ®Google Scholar
• Attiyeh EF, London WB, Mosse YP, et al. Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med. 2005;353:2243–2253. doi:10.1056/NEJMoa052399. PMID:16306521
   PubMed Web of Science ®Google Scholar
• Bown N, Cotterill S, Lastowska M, et al. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med. 1999;340:1954–1961. doi:10.1056/nejm199906243402504. PMID:10379019
   PubMed Web of Science ®Google Scholar
• Pugh TJ, Morozova O, Attiyeh EF, et al. The genetic landscape of high-risk neuroblastoma. Nat Genet. 2013;45:279–284. doi:10.1038/ng.2529. PMID:3682833
   PubMed Web of Science ®Google Scholar
• Shaikh TH, Gai X, Perin JC, et al. High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications. Genome Res. 2009;19:1682–1690. doi:10.1101/gr.083501.108. PMID:2752118
   PubMed Web of Science ®Google Scholar
• Suenaga Y, Islam SM, Alagu J, et al. NCYM, a Cis-Antisense Gene of MYCN, Encodes a De Novo Evolved Protein That Inhibits GSK3beta Resulting in the Stabilization of MYCN in Human Neuroblastomas. PLoS Genet. 2014;10:e1003996. doi:10.1371/journal.pgen.1003996. PMID:3879166
   PubMed Web of Science ®Google Scholar
• Liu PY, Erriquez D, Marshall GM, et al. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression. J Natl Cancer Inst. 2014;106: pii: dju113. doi:10.1093/jnci/dju113. PMID:24906397.
   Google Scholar
• Weiss WA, Aldape K, Mohapatra G, et al. Targeted expression of MYCN causes neuroblastoma in transgenic mice. Embo J. 1997;16:2985–2995. doi:10.1093/emboj/16.11.2985. PMID:9214616
   PubMed Web of Science ®Google Scholar
• Defferrari R, Tonini GP, Conte M, et al. Concomitant DDX1 and MYCN gain in neuroblastoma. Cancer Lett. .2007;256:56–63. doi:10.1016/j.canlet.2007.05.010. PMID:17611020
   PubMed Web of Science ®Google Scholar
• Bell JL, Turlapati R, Liu T, et al. IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma. J Clin Oncol. 2015;33:1285–1293. doi:10.1200/jco.2014.55.9880. PMID:25753434
   PubMed Web of Science ®Google Scholar
• Islam A, Kageyama H, Takada N, et al. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene. 2000;19:617–623. doi:10.1038/sj.onc.1203358. PMID:10698506
   PubMed Web of Science ®Google Scholar
• Caron H, van Sluis P, de Kraker J, et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med. 1996;334:225–230. doi:10.1056/nejm199601253340404. PMID:8531999
   PubMed Web of Science ®Google Scholar
• Henrich KO, Schwab M, Westermann F. 1p36 tumor suppression–a matter of dosage? Cancer Res. 2012;72:6079–6088. doi:10.1158/0008-5472.can-12-2230. PMID:23172308
   PubMed Web of Science ®Google Scholar
• Diskin SJ, Hou C, Glessner JT, et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature. 2009;459:987–991. doi:10.1038/nature08035. PMID:2755253
   PubMed Web of Science ®Google Scholar
• Wang K, Li M, Hadley D, et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 2007;17:1665–1674. doi:10.1101/gr.6861907. PMID:2045149
   PubMed Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2016.
   Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. In: Kotz S, Johnson N, editors. Breakthroughs in statistics. Springer Series in Satistics. New York (NY): Springer New York; 1992. p. 319–337.
   Google Scholar
• Therneau T [Internet]. Rochester (MN): Mayo Clinic; A Package for Survival Analysis in S. version 2.38. c2015 [cited 2017 July 17]. Available from: https://CRAN.R-project.org/package=survival
   Google Scholar
• Kassambara A, Kosinski M [Internet]. Marseille (France): Statistical tools for high throughput data analysis. Survminer: Drawing Survival Curves using ‘ggplot2’. 2016. c2016 [cited 2017 July 17]. Available from: http://www.sthda.com/english/rpkgs/survminer/.
   Google Scholar
• Goel MK, Khanna P, Kishore J. Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res. 2010;1:274–278. doi:10.4103/0974-7788.76794. PMID:3059453
   PubMedGoogle Scholar